Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Wildl Dis ; 58(4): 935-938, 2022 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-36240732

RESUMO

We unsuccessfully attempted to safely chemically immobilize a roan antelope (Hippotragus equinus) with a premixed combination of medetomidine (5 mg/mL) and ketamine (150 mg/mL) for injury treatment. This dose (0.066 mg/kg medetomidine and 1.96 mg/kg ketamine) produced poor quality of immobilization, probably exacerbated by stimulation before completing induction.


Assuntos
Ketamina , Medetomidina , Animais , Medetomidina/farmacologia
2.
J Wildl Dis ; 58(3): 636-640, 2022 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-35417919

RESUMO

We evaluated the safety and efficacy of nalbuphine (40 mg/mL), plus medetomidine (10 mg/mL), plus azaperone (10 mg/mL) under the premixed label NalMed-A. From January to March 2020, 10 aoudad (Ammotragus lervia) were immobilized via dart-gun for seven separate sampling periods for a total of 45 recorded individual immobilization events. Induction and reversal times with NalMed-A were 5.53±2.61 min and (following atipamezole administration) 5.08±2.43 min while previous studies with alpha-2 agonist-ketamine combinations gave median and average induction times of 4.6 min and 11.2 min using medetomidine-ketamine and xylazine-ketamine, respectively. Overall, NalMed-A adequately immobilized aoudad, with 13% incidence of hyperthermia and 2.22% mortality when delivered via dart.


Assuntos
Ketamina , Nalbufina , Animais , Azaperona/farmacologia , Combinação de Medicamentos , Hipnóticos e Sedativos/farmacologia , Imobilização/veterinária , Ketamina/farmacologia , Medetomidina/farmacologia , Nalbufina/farmacologia , Ruminantes
3.
Microbiol Spectr ; 10(2): e0057622, 2022 04 27.
Artigo em Inglês | MEDLINE | ID: mdl-35319276

RESUMO

Free-ranging white-tailed deer (Odocoileus virginianus) across the United States are increasingly recognized for infection and transmission of SARS-CoV-2. Through a cross-sectional study of 80 deer at three captive cervid facilities in central and southern Texas, we provide evidence of 34 of 36 (94.4%) white-tailed deer at a single captive cervid facility seropositive for SARS-CoV-2 by neutralization assay (PRNT90), with endpoint titers as high as 1,280. In contrast, all tested white-tailed deer and axis deer (Axis axis) at two other captive cervid facilities were seronegative, and SARS-CoV-2 RNA was not detected in respiratory swabs from deer at any of the three facilities. These data support transmission among captive deer that cannot be explained by human contact for each infected animal, as only a subset of the seropositive does had direct human contact. The facility seroprevalence was more than double of that reported from wild deer, suggesting that the confined environment may facilitate transmission. Further exploration of captive cervids and other managed animals for their role in the epizootiology of SARS-CoV-2 is critical for understanding impacts on animal health and the potential for spillback transmission to humans or other animal taxa. IMPORTANCE As SARS-CoV-2 vaccine coverage of the human population increases and variants of concern continue to emerge, identification of the epidemiologic importance of animal virus reservoirs is critical. We found that nearly all (94.4%) of the captive white-tailed deer at a cervid facility in central Texas had neutralizing antibodies for SARS-CoV-2. This seroprevalence is over double than that which has been reported from free-ranging deer from other regions of the United States. Horizontal transmission among deer may be facilitated in confinement. Tracking new infections among wild and confined deer is critical for understanding the importance of animal reservoirs for both veterinary and human health.


Assuntos
COVID-19 , Cervos , Animais , COVID-19/epidemiologia , COVID-19/veterinária , Vacinas contra COVID-19 , Estudos Transversais , Humanos , SARS-CoV-2 , Estudos Soroepidemiológicos , Texas/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...